Literature DB >> 536179

Carcinoma of the prostate. II. Serum activity of acid phosphatase, prostatic acid phosphatase, LDH and its isoenzymes.

J Mráz, F Vrubel, M Hanselová.   

Abstract

In 25 patients with carcinoma of the prostate (CaP) T3 and in a comparative group of 18 patients with BPH the serum enzymes of AP, tartrate labile AP, LDH, and iso-LDH were investigated simultaneously in basal conditions and after standardized transrectal prostatic biopsy. AP, PAP as well as LDH were shown to be of small diagnostic aid. The reaction of serum enzyme levels following the standardized prostatic biopsy was the same in both CaP and BPH patients. In studying LDH-isoenzymes, we found that the third fraction was elevated in almost all patients. This change is apparently not of prostatic origin, and we could not attribute it to the concomitant diseases found in some patients.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 536179     DOI: 10.1007/BF02086817

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  12 in total

1.  Lactic dehydrogenase production in tissue culture of normal, transformed, and malignant human cell lines.

Authors:  A E MOORE; F WROBLEWSKI
Journal:  Proc Soc Exp Biol Med       Date:  1958 Aug-Sep

2.  A method for estimating serum acid phosphatase of prostatic origin.

Authors:  W H FISHMAN; F LERNER
Journal:  J Biol Chem       Date:  1953-01       Impact factor: 5.157

3.  Separation of cells with histochemically demonstrable acid phosphatase activity from suspensions of human prostatic cells in an isokinetic gradient of Ficoll in tissue culture medium.

Authors:  S R Helms; F I Brazeal; A J Bueschen; T G Pretlow
Journal:  Am J Pathol       Date:  1975-07       Impact factor: 4.307

4.  AN " ACID " PHOSPHATASE OCCURRING IN THE SERUM OF PATIENTS WITH METASTASIZING CARCINOMA OF THE PROSTATE GLAND.

Authors:  A B Gutman; E B Gutman
Journal:  J Clin Invest       Date:  1938-07       Impact factor: 14.808

5.  Comparison of total and prostatic fraction serum acid phosphatase levels in patients with differentiated and undifferentiated prostatic carcinoma.

Authors:  G P Murphy; G Reynoso; G M Kenny; J F Gaeta
Journal:  Cancer       Date:  1969-06       Impact factor: 6.860

6.  Alterations in serum lactate dehydrogenase activity and its isoenzyme pattern after massage of the prostate. Value in differentiating carcinoma from benign hyperplasia of the prostate.

Authors:  T Ishibe
Journal:  Invest Urol       Date:  1971-09

7.  Studies on glycolytic enzymes in relation to cancer. 3. Clinical significance of serum phosphohexose isomerase and aldolase in cancer of the prostate. A comparative study with serum acid phosphatase and serum alkaline phosphatase.

Authors:  S R Damle; R V Talavdekar; T B Panse
Journal:  Indian J Cancer       Date:  1971-09       Impact factor: 1.224

8.  Bone marrow acid phosphatase: prognostic value in patients undergoing radical prostatectomy.

Authors:  R J Veenema; E O Gursel; N Romas; M Wechsler; J K Lattimer
Journal:  J Urol       Date:  1977-01       Impact factor: 7.450

9.  Carcinoma of the prostate. Enzyme histochemistry.

Authors:  J B Blennerhassett; R B Cohen; A L Vickery
Journal:  Cancer       Date:  1967-12       Impact factor: 6.860

10.  [The distribution of isoenzymes of lactate dehydrogenase in benign and malignant neoplasms of the human prostate (author's transl)].

Authors:  A Feustel; F Wohlrab; P Paschke; G Zochert
Journal:  Urol Int       Date:  1976       Impact factor: 2.089

View more
  1 in total

1.  Aberrant FGFR Tyrosine Kinase Signaling Enhances the Warburg Effect by Reprogramming LDH Isoform Expression and Activity in Prostate Cancer.

Authors:  Junchen Liu; Guo Chen; Zezhen Liu; Shaoyou Liu; Zhiduan Cai; Pan You; Yuepeng Ke; Li Lai; Yun Huang; Hongchang Gao; Liangcai Zhao; Helene Pelicano; Peng Huang; Wallace L McKeehan; Chin-Lee Wu; Cong Wang; Weide Zhong; Fen Wang
Journal:  Cancer Res       Date:  2018-06-11       Impact factor: 12.701

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.